(Q53272579)

English

Long-term efficacy and safety of a combination of sabal and urtica extract for lower urinary tract symptoms--a placebo-controlled, double-blind, multicenter trial.

scientific article published in June 2005

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/15928959

Long-term efficacy and safety of a combination of sabal and urtica extract for lower urinary tract symptoms--a placebo-controlled, double-blind, multicenter trial. (English)

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/15928959

1 reference

based on heuristic

inferred from title

multicenter clinical trial

1 reference

based on heuristic

inferred from title

author name string

N Lopatkin

1

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/15928959

A Sivkov

2

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/15928959

C Walther

3

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/15928959

S Schläfke

4

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/15928959

A Medvedev

5

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/15928959

J Avdeichuk

6

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/15928959

G Golubev

7

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/15928959

K Melnik

8

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/15928959

N Elenberger

9

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/15928959

U Engelmann

10

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/15928959

publication date

1 June 2005

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/15928959

World Journal of Urology

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/15928959

23

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/15928959

2

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/15928959

139-146

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/15928959

https://scigraph.springernature.com/pub.10.1007/s00345-005-0501-9

0 references

Combined sabal and urtica extract compared with finasteride in men with benign prostatic hyperplasia: analysis of prostate volume and therapeutic outcome.

1 reference

https://api.crossref.org/works/10.1007%2FS00345-005-0501-9

21 January 2018

A meta-analysis on the efficacy and tolerability of alpha1-adrenoceptor antagonists in patients with lower urinary tract symptoms suggestive of benign prostatic obstruction

1 reference

https://pubmed.ncbi.nlm.nih.gov/15928959

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antiproliferative effect of a polysaccharide fraction of a 20% methanolic extract of stinging nettle roots upon epithelial cells of the human prostate (LNCaP).

1 reference

https://pubmed.ncbi.nlm.nih.gov/15928959

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Combination of Sabal and Urtica extract vs. finasteride in benign prostatic hyperplasia (Aiken stages I to II). Comparison of therapeutic effectiveness in a one year double-blind study]

1 reference

https://pubmed.ncbi.nlm.nih.gov/15928959

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Results of a double-blind study on the effectiveness of ERU (extractum radicis Urticae) capsules in conservative treatment of benign prostatic hyperplasia

1 reference

https://pubmed.ncbi.nlm.nih.gov/15928959

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The effect of finasteride on the risk of acute urinary retention and the need for surgical treatment among men with benign prostatic hyperplasia. Finasteride Long-Term Efficacy and Safety Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/15928959

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Extracts from fruits of saw palmetto (Sabal serrulata) and roots of stinging nettle (Urtica dioica): viable alternatives in the medical treatment of benign prostatic hyperplasia and associated lower urinary tracts symptoms

1 reference

https://pubmed.ncbi.nlm.nih.gov/15928959

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of stinging nettle root extracts and their steroidal components on the Na+,K(+)-ATPase of the benign prostatic hyperplasia

1 reference

https://pubmed.ncbi.nlm.nih.gov/15928959

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Saw palmetto extracts for treatment of benign prostatic hyperplasia: a systematic review

1 reference

https://pubmed.ncbi.nlm.nih.gov/15928959

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Estimating a population's needs for the treatment of lower urinary tract symptoms in men: what is the extent of unmet need?

1 reference

https://pubmed.ncbi.nlm.nih.gov/15928959

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Changes in the Metabolism of Dihydrotestosterone in the Hyperplastic Human Prostate*

1 reference

https://pubmed.ncbi.nlm.nih.gov/15928959

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Saw palmetto extracts potently and noncompetitively inhibit human alpha1-adrenoceptors in vitro

1 reference

https://pubmed.ncbi.nlm.nih.gov/15928959

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Placebo therapy of benign prostatic hyperplasia: a 25-month study. Canadian PROSPECT Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/15928959

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phytotherapy for benign prostatic hyperplasia

1 reference

https://pubmed.ncbi.nlm.nih.gov/15928959

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Male lower urinary tract symptoms and related health care seeking in Germany

1 reference

https://pubmed.ncbi.nlm.nih.gov/15928959

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Variability and circadian changes in home uroflowmetry in patients with benign prostatic hyperplasia compared to normal controls.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15928959

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Placebo effects in the pharmacological treatment of uncomplicated benign prostatic hyperplasia. The ALFECH Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/15928959

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00345-005-0501-9

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/15928959

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/15928959

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53272579&oldid=1488703818"